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TESTING DRUGS VERSUS TESTING FOR DRUG USE:
PRIVATE RISK MANAGEMENT IN THE SHADOW
OF CRIMINAL LAW
Robert J. MacCoun*
INTRODUCTION
The rule of law is often seen as a formal, governmental alternative
to informal, social mechanisms for regulating conduct.' In this Arti-
cle, I examine a more indirect manifestation of the rule of law: the
indirect effect that criminal law can have on private risk management
efforts by individuals and corporations. Formal law can encourage
private risk regulation, but it can also distort it.
This Article examines the chemical testing of psychoactive drugs.
Trained technicians in commercial laboratories routinely employ a
common technology-gas chromatography/mass spectrometry (GC/
MS)-to test samples for the presence of illicit psychoactive sub-
stances as well as for dangerous or benign adulterants. One of these
laboratories, LabCorp, provides occupational testing services for cor-
porate clients.2 Another, Drug Detection Laboratories (DDL), con-
ducts GC/MS screening of samples provided by DanceSafe,
EcstasyData.org, and the Multidisciplinary Association for
Psychedelic Studies (MAPS). 3 LabCorp's samples are obtained from
corporate clients' random or systematic urine testing of their prospec-
tive and existing employees. DDL's samples come from anonymous
Ecstasy consumers who seek information on the potential presence of
adulterants in samples they have purchased illicitly.
This Article explores the remarkably different normative and be-
havioral consequences that follow from the use of the same basic labo-
* Professor of Law, Professor of Public Policy, and Affiliated Professor of Psychology, Uni-
versity of California at Berkeley. I am grateful to Susan Dennehy, Janette Catron, and Jennifer
Taylor for their assistance and helpful conversations, and to Jon Caulkins and Mark Kleiman for
valuable comments.
1. See, e.g., DONALD BLACK, THE BEHAVIOR OF LAW 107 (1976) ("Law varies inversely with
other social control." (emphasis omitted)).
2. LabCorp Solutions: Toxicology Frequently Asked Questions, http://www.labcorpsolutions.
com/toxicfaq.html (last visited Feb. 5, 2007).
3. EcstasyData.org: Data Frequently Asked Questions, http://www.ecstasydata.org/
about-data-faq.php#gcms (last visited Feb. 5, 2007).
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ratory protocol to test for illicit drug use (use testing)4 and for illicit
drug safety (safety testing).s My primary interest is in testing practices
conducted by private citizens rather than agents of the legal system.
At first glance, one might think that safety testing and use testing have
little shared relevance. I do not contend that they are mutually exclu-
sive alternatives. Both use testing and safety testing are intended to
reduce harms, and each presumes to do so indirectly, by influencing
the decision to ingest a drug. But these practices exemplify two dis-
tinctly different strategies for thinking about the management of risky
behaviors-prevalence reduction and harm reduction. Prevalence re-
duction seeks to reduce the number of people engaging in a given
behavior, while harm reduction seeks to reduce the harmful conse-
quences of engaging in such behavior. 6 Practices and concepts most
readily identified with prevalence reduction include abstinence, pre-
vention, deterrence, and incapacitation. Practices and concepts most
readily identified with harm reduction include safe-use and safe-sex
educational materials, needle exchanges, and the free distribution of
condoms to students. Prevalence reduction may be employed in the
hope of reducing drug-related harms, but because it directly targets
use, any influence on harm is indirect. Harm reduction directly
targets harms; any influence on use is indirect.
This Article focuses on the private use of these methodologies.
These private uses occur in the shadow of the law, thus criminal law
influences-and, to some extent, distorts-their consequences. Crimi-
nal law facilitates the intrusive exercise of use testing in workplaces
and schools that might otherwise have difficulty implementing it; this
is illustrated by the greater prevalence of drug testing than of alcohol
testing.7 Criminal law also hinders the effective implementation of
safety testing, making it easier for sellers to distribute adulterated and
often dangerous products. More subtly, criminal law frames the issue
of drug use as one of criminal deviance, which encourages some solu-
tions but obscures others. For example, the focus on use testing over-
looks the potential benefits of psychomotor testing, which may be
4. I refer to "use testing" as testing an individual's urine, blood, hair, or saliva for the presence
of illicit drugs.
5. I refer to "safety testing" as testing purchased drugs to determine their purity and to detect
the presence of adulterants.
6. See ROBERT J. MACCOuN & PETER REUTER, DRUG WAR HERESIES: LEARNING FROM
OTHER VICES. TIMES. AND PLACES tbl.15.1 at 386 (2001) [hereinafter MACCOuN & REUTER,
DRUG WAR HERESIES]; Robert J. MacCoun, Toward a Psychology of Harm Reduction, 53 AM.
PSYCHOLOGIST 1199, 1199 (1998) [hereinafter MacCoun, Psychology of Harm Reduction].
7. Alcohol testing, however, does occur, which shows that criminal prohibition is not a prereq-
uisite for testing.
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more effective in reducing harms. 8 Thus, both practices are con-
strained by the criminal laws prohibiting these drugs. This is not an
argument for ending drug prohibition, nor do I argue for the superior-
ity of safety testing over use testing, or harm reduction over preva-
lence reduction. 9 But this Article suggests a less moralistic, more
pragmatic approach to drug policy-an approach that is less specula-
tive than legalization because it has been pursued for decades in the
Netherlands, and increasingly in the United Kingdom, Australia, and
elsewhere. 10
II. USE TESTING
Part II of this Article presents an empirical review of several studies
of use testing. Use testing is examined in several different contexts:
in the workplace, in schools, and in the criminal justice system. The
results of these studies are surveyed, and the effects of use testing on
both prevalence reduction and harm reduction are analyzed.
A. Prevalence of Testing
1. Testing in the Workplace
Workplace drug testing is now fairly common, as exhibited in the
1994 and 1997 versions of the National Household Survey on Drug
Abuse (NHSDA).I 1 These surveys show that 49% of workers in 1997,
and 44% in 1994, reported that their workplaces conducted drug test-
ing; testing was more common in large firms (74%) than in medium
(58%) or small (28%) firms.' 2 According to the American Manage-
ment Association, the proportion of its members using drug testing
rose from 21% to 81% between 1987 and 1996.13 The NHSDA study
8. Psychomotor testing involves various tools for assessing physical performance of tasks-
e.g., reaction time testing, speed-accuracy trade-offs, and hand-eye coordination. See infra Part
lI.D.
9. See generally MACCOUN & REUTER, DRUG WAR HERESIES, supra note 6.
10. See Robert MacCoun & Peter Reuter, Preface: The Varieties of Drug Control at the Dawn
of the Twenty-First Century, 582 ANNALS AM. ACAD. POL. & Soc. Sci. 7, 10-11 (2002); Robert J.
MacCoun & Peter Reuter, Does Europe Do It Better?: Lessons from Holland, Britain and Swit-
zerland, NATION, Sept. 20, 1999, at 28.
11. The 1994 and 1997 NHSDA reports each included a special module of items assessing
respondents' workplace characteristics. See SAMHSA, DEP'T OF HEALTH & HUMAN SERVS.,
WORKER DRUG USE AND WORKPLACE POLICIES AND PROGRAMS: RESULTS FROM THE 1994
AND 1997 NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE (1999), available at http://www.
oas.samhsa.gov/NHSDA/A-11/WrkplcPlcy2.htm [hereinafter NHSDA RESULTS].
12. Id. §§ 5.1, 5.3.
13. NAT'L RESEARCH COUNCIL, INFORMING AMERICA'S POLICY ON ILLEGAL DRUGS: WHAT
WE DON'T KNOW KEEPS HURTING Us 198 (Charles F. Manski et al. eds., 2001) [hereinafter
INFORMING AMERICA'S POLICY].
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found that pre-employment testing was more common (39%) than ei-
ther testing for cause (30%) or random testing (25%).14 Similarly, a
National Institute on Drug Abuse (NIDA) survey of workplace drug
testing data in the early 1990s found that pre-employment testing was
more common (44% of testing firms) than random testing (27% of
testing firms).15
In the NHSDA study, about 8% of full-time workers reported using
illicit drugs during the month; a similar share reported heavy alcohol
use.16 Full-time workers accounted for 70% of current illicit drug
users aged 18 to 49.17 Because the household survey likely excluded a
sizeable fraction of the addicted population, the true employment rate
among current drug users is surely lower. 8 Nevertheless, this suggests
an upper-bound estimate that a third (viz., 49% x 70% = 34%) of
current adult drug users are subject to drug-testing surveillance.
2. Testing in Schools
In the 1998 Monitoring the Future survey of high school seniors,
14% of schools and 16% of students reported having some form of
drug testing.1 9 Similar testing rates (16% of schools and 16% of stu-
dents) were found in 2001.20 A somewhat lower rate was reported by
the National Study of Delinquency Prevention in Schools (NSDPS),
which relied on administrative rather than student respondents. It
found that from 1997 to 1998, "approximately 9 percent of secondary
schools conduct[ed] some sort of testing program, presumably focused
on athletes. ' 21 This estimate covers a time period just after the Su-
preme Court held in Vernonia School District 47J v. Acton22 that
mandatory drug testing of student athletes is legal under the Fourth
14. NHSDA RESULTS, supra note 11, fig.5.1.
15. NAT'L ACAD. OF SCIS., UNDER THE INFLUENCE?: DRUGS AND THE AMERICAN WORK
FORCE 77 (Jacques Normand et al. eds., 1994) [hereinafter UNDER THE INFLUENCE].
16. NHSDA RESULTS, supra note 11, tbl.l.1.
17. Id.
18. See Peter Reuter, Drug Use Measures: What Are They Really Telling Us?, NAT'L INST.
JUST. J., Apr. 1999, at 13 (discussing the underrepresentation of hard-core users in household
surveys).
19. Ryoko Yamaguchi et al., Relationship Between Student Illicit Drug Use and School Drug-
Testing Policies, 73 J. SCH. HEALTH 159 tbl.1 at 160 (2003).
20. Id.
21. INFORMING AMERICA'S POLICY, supra note 13, at 203. The NSDPS final reports do not
appear to present any results on drug testing. See GARY D. GOITFREDSON ET AL., U.S. DEP'T
OF JUSTICE, NATIONAL STUDY OF DELINQUENCY PREVENTION IN SCHOOLS (2000), available at
http://www.ncjrs.org/pdffilesl/nij/grants/194129.pdf; U.S. DEP'T OF JUSTICE, TOWARD SAFE AND
ORDERLY SCHOOLS-THE NATIONAL STUDY OF DELINQUENCY PREVENTION IN SCHOOLS
(2004), available at http://www.ncjrs.gov/pdffilesl/nij/205005.pdf.
22. 515 U.S. 646 (1995).
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and Fourteenth Amendments. A later opinion by Justice Clarence
Thomas in Board of Education of Independent School District No. 92
of Pottawatomie County v. Earls2 3 further established student drug
testing by holding that it "is a reasonably effective means of address-
ing the School District's legitimate concerns in preventing, deterring,
and detecting drug use" among schoolchildren. 24
3. Testing in the Criminal Justice System
Most of what we know about drug use among arrestees comes from
urinalyses conducted for research purposes, rather than for criminal
processing. Drug testing of arrestees is rare, except in Washington,
D.C. and jurisdictions participating in the Treatment Alternatives for
Special Clients (TASC) 25 program or the recently cancelled Arrestee
Drug Abuse Monitoring (ADAM) program. Most probationers and
parolees are technically subject to testing, but it is very infrequent.2 6
Based on his recent study in Los Angeles, San Diego, and Santa Cruz
Counties, Professor Mark Kleiman and his colleagues argue that test-
ing of probationers is an inadequate means of surveillance and
monitoring:
Once-a-week testing produces about a 35% chance of detecting any
given incident of drug use; twice a week pushes that figure above
80%. By contrast, a probationer tested once a month-a far more
typical pattern in the three departments studied-has less than one
chance in ten of being detected for any given incident of use.27
One might assume that the criminal justice system occupies the
most intrusive and punitive end of the drug testing spectrum, but Eric
Wish and Bernard Gropper of the National Institute of Justice note
that in such settings "a single positive test result will seldom have the
drastic consequences it can have in the employment setting. '2 8 They
argue that "[t]he level of recent drug use in the offender population is
so high that it would be counterproductive to attempt to revoke pro-
23. 536 U.S. 822 (2002).
24. Id. at 837.
25. TASC originally stood for the "Treatment Alternatives to Street Crimes," but now stands
for the "Treatment Alternatives for Special Clients."
26. See Adele Harrell & Mark Kleiman, Drug Testing in Criminal Justice Settings, in TREAT-
MENT OF DRUG OFFENDERS: POLICIES AND ISSUES 149 (Carl G. Leukefeld et al. eds., 2002); Eric
D. Wish & Bernard A. Gropper, Drug Testing by the Criminal Justice System: Methods, Re-
search, and Applications, 13 CRIME & JUST. REV. RES. 321, 354 (1990); D. Alan Henry & John
Clark, Pretrial Drug Testing: An Overview of Issues and Practices, BUREAU JUST. ASSISTANCE
BULL., July 1999, at 1.
27. Mark A.R. Kleiman et al., Opportunities and Barriers in Probation Reform: A Case Study
of Drug Testing and Sanctions, 14 CAL. POL'Y RES. CTR. BRIEF, June 2002.
28. Wish & Gropper, supra note 26, at 334.
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bation or parole or incarcerate all persons who tested positive. '29 In-
stead, a positive test is usually "used to trigger more assessment,
testing, or supervision and not to punish people or deprive them of
their liberty."'30
B. Testing Results
Quest Diagnostics, "the leading provider of employer drug testing
services in the United States," publishes a regular Drug Testing Index
summarizing its results.31 Between January 2005 and June 2005,
Quest conducted over 3.6 million drug tests; the positivity rate was 5%
for the general U.S. workforce and 2% for federal workers in safety-
sensitive positions.32 The results show a general decline in positivity
rates in recent years, particularly for marijuana. An early 1990s
NIDA survey of workplace drug testing found that almost 4% of sam-
ples were positive for an illicit substance: 2% for marijuana, 1% for
cocaine, and less than 1% for opiates and benzodiazepines. 33 Positive
rates were highest in the construction sector at 6%, compared to only
3% for the retail sector and 2% for both the manufacturing and trans-
portation sectors.34
Not surprisingly, positive drug test rates are dramatically higher
among criminal justice arrestees. The National Institute of Justice be-
gan collecting systematic drug testing data from arrestees with its
Drug Use Forecasting (DUF) program in 1988. An improved meth-
odology, the ADAM program, was implemented in 2000. 35 The most
recent data available are from 2000.36 In that year, more than half of
thirty-five sites reported that 64% or more of their male arrestees
tested positive for either cocaine, opiates, marijuana, methampheta-
mine, or PCP (the NIDA-5). 37 The most common drugs present were
marijuana (40%) and cocaine (30%).38
Any consideration of drug test results should be qualified by the
serious limitations of existing testing methods. Blood testing is the
29. Id. (citation omitted).
30. Id. at 335.
31. Quest Diagnostics Drug Testing Index: Employer Solutions, http://www.questdiagnostics.
com/employersolutions/DTI11 2005/dtiindex.html (last visited Feb. 5, 2007).
32. Id.
33. UNDER THE INFLUENCE, supra note 15, at 75.
34. Id. fig.3.10 at 79.
35. The program ended on January 29, 2004, depriving criminologists of one of the few sys-
tematic tools available for tracking the links between drug use and criminality.
36. U.S. DEP'T OF JUSTICE. 2000 ARRESTEE DRUG ABUSE MONITORING: ANNUAL REPORT
(2003), available at http://www.ncjrs.gov/pdffilesl/nij/193013.pdf.
37. Id. at 1.
38. Id.
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most accurate method for identifying drug influences at the moment
of testing, but it is intrusive, expensive, and rare.39 Urine testing,
which is also intrusive, is far more common. But it is a poor indicator
of immediate drug status because drugs cannot be detected in urine
until they have been metabolized, often many hours after consump-
tion. 40 Urine testing is particularly sensitive to cannabis use, and can
detect use dating back several months for a heavy user, but it is far
less likely to detect other "hard" drugs. Saliva and hair testing are less
intrusive and are becoming more common. In fact, hair testing can
detect use dating back two to three months, and can even date the use
with some accuracy. 41
Use testing is vulnerable to false positives due to contaminants (for
urine testing), as well as false negatives due to temporary abstention
(for blood, urine, and saliva testing), "water loading" (for urine test-
ing), and even a haircut (for hair testing). Detailed advice on defeat-
ing a drug test is available on various websites.42 For example, false
positives for marijuana can be triggered by many different prescrip-
tion and over-the-counter medications.43
Another reason to be wary of the accuracy of use testing results is
problems with sampling. "Random testing" may sound a lot like "ran-
dom sampling," but there is selection into and out of the sample, be-
cause users and others who object to testing may avoid the testing
39. Erowid Drug Testing Vaults: The Basics, http://www.erowid.org/psychoactives/testing/test-
ingjinfol.shtml (last visited Feb. 5, 2007).
40. OFFICE OF NAT'L DRUG CONTROL POLICY, WHAT You NEED TO KNOW ABOUT DRUG
TESTING IN SCHOOLS 9 (2002), available at http://www.whitehousedrugpolicy.gov/pdf/
drug-testing.pdf.
41. For a detailed review of hair testing accuracy, see R. Wennig, Potential Problems with the
Interpretation of Hair Analysis Results, 107 FORENSIC SCI. INT'L 5 (2000).
42. See, e.g., The Drug Testing FAQ (v.4.11), http://cocaine.org/drugtestfaq/index.html (last
visited Feb. 5, 2007): Drug Tests Facts & Frequently Asked Questions, http://www.ipas-
sedmydrugtest.com/drugtest-faq.asp (last visited Feb. 5, 2007) [hereinafter Drug Test Facts].
43. According to www.ipassedmydrugtest.com, these drugs include several readily available
medications:
Over-the-counter NSAIDS: Ibuprofen; Advil, Nuprin, Mediprim, Motrin, Bayer Se-
lect Pain Relief Formula, Excedrin 1B Caplets, Genpril, Haltran, lbuprin, Midol 200,
Pamprin, Trendar Cramp Relief Formula, Cramp End Tablets, Medipren, Rufln,
Naproxen, Aleve, Ketoprofen, Orudis KT. Prescription NSAIDS: Anaprox, Tolectin,
ifenoprofen, flurbiprofen, oxaprozin, Ansaid, Clinoril, Dolobid, Feldene, Indocin,
Lodine, Meclomen, Motrin, Nalfon, Naprosyn, Orudis, Relafen, Voltaren. Over-the-
counter allergy preparations, sleep aids and antinausea medications that contain
promethazine: Phenergan, Promethegan, Riboflavin (vitamin B2), Dronabinol, [and]
Edecrin.
Drug Tests Facts, supra note 42.
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organization altogether-whether it be the military, a workplace, or a
school sports program.44
C. Effects on Drug Use
From a deterrence perspective, use testing should be an effective
way to reduce drug use. Aggregate econometric analyses and individ-
ual-level "perceptual deterrence" studies suggest four generalizations
about drug offenses, drunk driving, and various income-generating
crimes: (1) the certainty of punishment has a modest but reliable
causal impact on offending rates, even for offenses with very low de-
tection probabilities; (2) the severity of punishment has no reliable
impact, either in isolation or in interaction with certainty; (3) the ce-
lerity or speed of punishment is important, but post-arrest criminal
sanctioning is probably too slow to be effective; and (4) an arrest can
trigger informal social sanctions, even in the absence of
incarceration.45
Use testing increases the certainty of sanctioning, and even when it
does not lead to arrest, the consequences of a positive test are effec-
tively punitive, because it damages one's reputation with family,
friends, and colleagues. Nevertheless, support for a general deterrent
effect of drug testing is mixed.
The available studies are correlational and hence subject to a vari-
ety of inferential problems. It is astonishing that such an intrusive
intervention is being implemented so widely in the absence of a care-
fully controlled experiment group, with random assignment to testing
condition either at the individual, site, or organizational level. 46
On the basis of the special workplace modules, the NHSDA 1994/
1997 project noted the effect of information availability in the
workplace:
There is evidence that workplace policies matter. Employees in
three of the four occupations with the lowest rates of drug use (pro-
tective service, extraction and precision production, and administra-
tion support) were also among employees in the four occupations
44. For a discussion of the possible consequences of this selection process, see infra Part II.D.
45. See NAT'L INST. OF JUSTICE, U.S. DEP'T OF JUSTICE, PERSPECTIVES ON CRIME AND JUS-
TICE: 1998-1999 LECTURE SERIES 6, 22 (1999), available at http://www.ncjrs.gov/pdffilesl/nij/
178244.pdf; Robert J. MacCoun, Drugs and the Law: A Psychological Analysis of Drug Prohibi-
tion, 113 PSYCHOL. BULL. 497, 498-99, 501, 505 (1993) [hereinafter MacCoun, Drugs and the
Law]; Daniel S. Nagin & Greg Pogarsky, Integrating Celerity, Impulsivity, and Extralegal Sanc-
tion Threats into a Model of General Deterrence: Theory and Evidence, 39 CRIMINOLOGY 865,
865-66, 873-74 (2001).
46. This complaint applies more generally to most drug policy interventions, with the excep-
tion of classroom prevention programs. See INFORMING AMERICA'S POLICY, supra note 13, at
188, 198-99.
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with the highest rates of drug information and policies in the
workplace.
47
In 1981, the U.S. military implemented a tough "zero-tolerance"
drug policy, which imposed mandatory drug testing and threatened
job termination for violations. Two studies have examined the effects
of the policy. Professor Jerald Bachman and his colleagues used the
Monitoring the Future cohort data from young adults who graduated
from high school between 1976 and 1995.48 They found declining
rates of drug use among active duty military personnel and nonmili-
tary cohort members in the two years after graduation, but beginning
in 1981, the rate of decline was steeper for the military group, at least
for illicit drugs. This is a pattern "strongly suggestive of causal rela-
tionships. ' 49 In a separate study, economists Stephen Mehay and
Rosalie Pacula compared NHSDA and Department of Defense health
survey data collected before and after the military adopted the zero-
tolerance policy.50 They estimated a 16% drop in the prevalence of
past-year drug use in the military, with a lower bound estimate of
4%.51
Dr. W. Robert Lange and his colleagues examined the effects of a
decision at Johns Hopkins hospital to shift from "for cause" employee
testing in 1989 to universal pre-employment testing in 1991.52 In 1989,
10.8% of 593 specimens were positive-55% of them for marijuana-
and there were seven "walkouts" who refused to be tested. 53 In 1991,
5.8% of 365 specimens tested positive-28% for marijuana-with no
walkouts. 54 The authors interpreted these results as evidence of the
deterrent effect of drug testing.55 But Professors M.R. Levine and
W.P. Rennie offer a variety of alternative explanations, including the
fact that in 1991 users had advance warning of the test and could ab-
47. NHSDA RESULTS, supra note 11, § 7.1.
48. Jerald G. Bachman et al., Changing Patterns of Drug Use Among US Military Recruits
Before and After Enlistment, 89 AM. J. PUB. HEALTH 672 (1999).
49. Id. at 675.
50. Stephen L. Mehay & Rosalie Liccardo Pacula, The Effectiveness of Workplace Drug Pre-
vention Policies: Does "Zero Tolerance" Work? (Nat'l Bureau of Econ. Research, Working
Paper No. 7383, 1999), available at http://www.nber.org/papers/w7383.
51. Id. at 21.
52. W. Robert Lange et al., Preemployment Drug Screening at the Johns Hopkins Hospital,
1989 and 1991, 20 AM. J. DRUG & ALCOHOL ABUSE 35, 36-38 (1994).
53. Id. at 40-41.
54. Id.
55. Id. at 44-45.
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stain, water load, or ingest legal substances that would confound the
test.5
6
The most comprehensive study of the effects of school testing on
student drug use comes from analyses of data from the Monitoring the
Future survey.5 7 This analysis found no measurable association be-
tween either random or "for cause" drug testing and students' self-
reported drug use.5 8 The study is cross-sectional, rather than prospec-
tive, and is somewhat limited by the relative rarity of exposure to
testing.
A more focused test was provided by the "pilot test" of the Student
Athlete Testing Using Random Notification (SATURN) project. 59
During the 1999-2000 academic year, the authors compared two Ore-
gon schools using mandatory drug testing with another school that did
not.60 Neither students nor schools were randomly assigned to drug
testing versus nontesting.6t The authors reported a significant treat-
ment effect; though statistical details were not presented, the conclu-
sion is apparently based on a difference-in-difference estimate of
changes from pre- to post-test in the control versus treatment
schools. 62 But caution is warranted for several reasons. First, al-
though there was a slight decrease in drug use at the treatment schools
(33% to 31% for past-month use), the effect is largely attributable to
an increase in drug use at the control schools (34% to 42%).63 Be-
cause assignment to condition was not random, there is little reason to
believe that a similar increase would have occurred at the treatment
schools absent testing. Second, most drug use risk factors, including
drug use norms, belief in lower consequences of drug use, and nega-
tive attitudes toward school, actually increased among the target
group-athletes at the treatment school. 64 These puzzling results may
56. M.R. Levine & W.P. Rennie, Pre-employment Urine Drug Testing of Hospital Employees:
Future Questions and Review of Current Literature, 61 OCCUPATIONAL & ENVTL. MED. 318, 322
(2004).
57. For an initial study, see Yamaguchi et al., supra note 19. For an extended analysis adding
the 2002 data, see Ryoko Yamaguchi et al., Drug Testing in Schools: Policies, Practices, and
Association with Student Drug Use (Inst. for Soc. Research, Univ. of Mich. Occasional Paper No.
2, 2003).
58. Yamaguchi et al., supra note 19.
59. Linn Goldberg et al., Drug Testing Athletes to Prevent Substance Abuse: Background and
Pilot Study Results of the SATURN (Student Athlete Testing Using Random Notification) Study,
32 J. ADOLESCENT HEALTH 16 (2003).
60. Id. at 17.
61. Id. at 24 ("Although there is an experimental and control school, they were not random-
ized, but rather self-selected.").
62. See id. tbl.3 at 22.
63. Id.
64. Id. at 22-24.
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explain why the study was labeled a pilot test, and why a more ambi-
tious and rigorous follow-up study was launched. Unfortunately, the
study was terminated by the Federal Office for Human Research Pro-
tection due to human protection concerns.65
At present, the evidence suggests that the military's testing program
had a deterrent effect, but no such effect was found in workplaces or
in schools. Still, the absence of evidence is not evidence of absence.
There are very few rigorous studies; low statistical power, noisy mea-
surement, and other factors may hide genuine effects. Alternatively,
the military program may be more effective as a deterrent due to dif-
ferences in its implementation, its target population, its consequences
for users, or its institutional setting.
D. Effects on Drug-Related Harm
Proponents of use testing see both use reduction (deterrence) and
harm reduction (safety) benefits of testing. In the courts, the harm
reduction rationale has generally trumped the use reduction rationale.
For example, in Vernonia, the Court held that the importance of de-
terring drug use among schoolchildren "can hardly be doubted. '66
But the Court focused on the harm reduction benefits of use testing:
"[I]t must not be lost sight of that this program is directed more nar-
rowly to drug use by school athletes, where the risk of immediate
physical harm to the drug user or those with whom he is playing his
sport is particularly high."'67 The D.C. Circuit has ruled that random
testing is an unreasonable invasion of employee privacy except for
safety-sensitive positions. 68 Based on its reading of three Supreme
Court decisions,69 the Substance Abuse and Mental Health Services
Administration has identified four classes of presumptive testing-
employees who carry firearms, motor vehicle operators carrying pas-
sengers, aviation flight crew members and air traffic controllers, and
railroad operating crews-"that are to be included in every plan if
such positions exist in the agency."70
65. The authors of the SATURN study defended it against these criticisms. Gary T. Chiodo et
al., Orbiting SATURN: Countering Politically-Charged Misinformation with Facts, 4 Am. J.
BIOETHIcs 43 (2004).
66. 515 U.S. 646, 661 (1995).
67. Id. at 662.
68. Harmon v. Thornburgh, 878 F.2d 484 (D.C. Cir. 1989).
69. See Vernonia, 515 U.S. 646; Nat'l Treasury Employees Union v. Von Raab, 489 U.S. 656
(1989); Skinner v. Ry. Labor Executives' Ass'n, 489 U.S. 602 (1989).
70. Federal Drug-Free Workplace Programs: Guidance for Selection of Testing Designated
Positions (TDP's) (Aug. 2, 1999), http://dwp.samhsa.gov/FedPgms/FileslTDPs.aspx.
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The National Research Council (NRC) took a comprehensive look
at the evidence for a safety-promoting benefit of drug testing in the
workplace. They concluded that the evidence linking alcohol and
drug use to workplace accidents Was largely inconclusive, 7' partly be-
cause both workplace accidents and workplace intoxication were rela-
tively rare events:
Despite the wide variety of research in the studies reviewed above,
few definitive statements can be made about the impact of using
alcohol and other drugs on job performance. The abundance of evi-
dence presented here indicates that the relationship between use
and job behaviors and outcomes is clearly negative. However, the
magnitude of the relationships found is generally small, and causal
spuriousness and direction are problems that have not been ade-
quately addressed in the literature.72
The intuition that drug testing might prevent accidents involves an
implicit causal chain: drug use impairs psychomotor functioning,
which in turn enhances accident risk. Drug testing is designed to de-
tect drug use, the earliest link in the chain, and hopefully to deter or
prevent it. But the model also explicitly demonstrates some of the
drawbacks of relying on drug use to prevent accidents. This point is
illustrated by the statistical logic of "path analysis," first articulated by
mathematician Sewall Wright in 1934. 73 In a causal chain (for exam-
ple, A--B---C) where the effect of a variable at one end (A) on the
other end (C) is "mediated" by a variable in the middle (B), the distal
A--C correlation equals the product of the two intermediate correla-
tions, and will thus be smaller than either one.74 Figure 1 demon-
strates the consequences for prediction. The percentage of variance in
accident risk due to drug use will drop rapidly with less than perfect
correlation in the two intermediate links in the chain. At every point,
71. UNDER THE INFLUENCE, supra note 15, at 144.
72. Id. at 158.
73. Sewall Wright, The Method of Path Coefficients, 5 ANNALS MATHEMATICAL STAT. 161
(1934).
74. See generally HERBERT B. ASHER, CAUSAL MODELING (1976); JOHN C. LOEHLIN, LATENT
VARIABLE MODELS: AN INTRODUCTION TO FACTOR, PATH, AND STRUCTURAL ANALYSIS
(1987); JUDEA PEARL, CAUSALITY: MODELS, REASONING, AND INFERENCE (2000); Reuben M.
Baron & David A. Kenny, The Moderator-Mediator Variable Distinction in Social Psychological
Research: Conceptual, Strategic, and Statistical Considerations, 51 J. PERSONALITY & SOC.
PSYCHOL. 1173 (1986). The use of path analysis to infer causal structure is problematic because
of various statistical threats to validity, involving bidirectional association, omitted variables, and
measurement error. But my argument is about the actual causal structure among latent con-
structs, not about the observed relationships among measured indicator variables.
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the psychomotor functioning variable will be a better predictor of ac-
cidents than the drug use variable.75
FIGURE 1:
DRUG
VARIANCE IN ACCIDENT RISK ACCOUNTED FOR BY
USE, IF PSYCHOMOTOR FUNCTIONING MEDIATES
THE DRUG-ACCIDENT RELATIONSHIP
-100%
unctioning-80
" -70%
60%
% of variance in
accident risk
50% accounted for
by drug use
Psychomotor-accident correlation
A potential objection to this causal chain model is that drug use
might have an additional indirect association with accident risk
through some common cause, such as poor self-control skills. The
NRC committee noted that any observed link between drug use and
accidents or work behavior could be spurious, due to common causa-
tion by a third variable. The committee offered this hypothesis:
"[Dieviance may be a better explanation than impairment of the links
between alcohol and other drug use and undesirable work behavior.
If so, confronting deviant behaviors and attitudes may be a more ef-
fective strategy than narrow antidrug programs for both preventing
workplace decrements and treating poorly performing workers. '76
From a prediction standpoint, one might argue that drug tests can
serve as a double proxy for drug use and low self-control. But psycho-
metrically, a better strategy would be to directly assess low self-con-
75. It is significant to note that the picture is even more bleak because drug tests are an
imperfect proxy for drug use.
76. UNDER THE INFLUENCE, supra note 15, at 133.
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trol and psychomotor functioning, as illustrated in Figure 2.
Psychologists and ergonomic specialists have developed a wide variety
of valid psychomotor tests, and many are already in use in the military
and other "mission-critical" organizations. 77 The private sector has
also begun to recognize the potential advantages of directly testing
impaired psychomotor performance. 78 There are a variety of psycho-
metrically reliable and valid measures of impulsivity, sensation-seek-
ing, and self-control. 79 More controversially, there are paper-and-
pencil "integrity tests" that allow corporations to assess drug and alco-
hol use, honesty, and other behavioral factors. 80
Psychomotor testing and integrity testing need not replace drug
testing; they can complement it. They may be less intrusive 81 and, in
the case of psychomotor testing, more diagnostic of accidents. Of
77. See generally FED. MOTOR CARRIER SAFETY ADMIN., U.S. DEP'T OF TRANSP., INDIVID-
UAL DIFFERENCE AND THE "HIGH RISK" COMMERCIAL DRIVER (2004); Rebecca S. Spicer et al.,
Worker Substance Use, Workplace Problems and the Risk of Occupational Injury: A Matched
Case-Control Study, 64 J. STUD. ON ALCOHOL 570 (2003); R.S. Kennedy et al., Application of a
Computerized Battery of Mental Tests for Driving and Workplace Safety (presented at the Int'l
Conference on Alcohol, Drugs & Traffic Safety, 2000), http://www.icadts.org/proceedings/2000/
icadts2000-149.pdf.
78. See Vendors Promote Performance Testing as Better Way to Measure Impairment, NAT'L
REP. ON SUBSTANCE ABUSE, Mar. 12, 1993, at 4; National Workrights Institute Impairment Test-
ing, http://www.workrights.org/issue-drugtest/dt-impairment-testing.html (last visited Feb. 5,
2007). In 1995, only 7% of worksites used performance testing. Tyler D. Hartwell et al., Work-
place Alcohol-Testing Programs: Prevalence and Trends, 121 MONTHLY LAB. REV. 27 tbl.4 at 32
(1998).
79. See G. Scott Acton, Measurement of Impulsivity in a Hierarchical Model of Personality
Traits: Implications for Substance Use, 38 SUBSTANCE USE & MISUSE 67 (2003); Jeffrey Arnett,
Sensation Seeking: A.New Conceptualization and a New Scale, 16 PERSONALITY & INDIVIDUAL
DIFFERENCES 289 (1994); Paula Horvath & Marvin Zuckerman, Sensation Seeking, Risk Ap-
praisal, and Risky Behavior, 14 PERSONALITY & INDIVIDUAL DIFFERENCES 41 (1993); Alex R.
Piquero & Andre B. Rosay, The Reliability and Validity of Grasmick et al.'s Self-Control Scale:
A Comment on Longshore et al., 36 CRIMINOLOGY 157 (1998).
80. See Wayne J. Camara & Dianne L. Schneider, Integrity Tests: Facts and Unresolved Issues,
49 AM. PSYCHOLOGIST 112 (1994). In a meta-analysis of 665 estimates, integrity tests had valid-
ity coefficients of 0.41 and 0.52 for supervisory ratings of job performance and predicting job
accidents, respectively. Deniz S. Ones et al., Comprehensive Meta-analysis of Integrity Test Va-
lidities: Findings and Implications for Personnel Selection and Theories of Job Performance, 78 J.
APPLIED PSYCHOL. 679 (1993). While integrity test performance can be faked, the resulting bias
does not eliminate its usefulness. In one study, the predictive validity of the test was 0.26 among
fakers. Ronald D. Pannone, Predicting Test Performance: A Content Valid Approach to Screen-
ing Applicants, 37 PERSONNEL PSYCHOL. 507, 511-12 (1984). This is lower than the validity for
nonfakers (0.55), but still higher than typical estimates for the validity of the most popular
screening method: the job interview. Id. Integrity tests also predict drug and alcohol use, with
validity coefficients around 0.30. Frank L. Schmidt et al., Validity of Integrity Tests for Predicting
Drug and Alcohol Abuse: A Meta-analysis, in NAT'L INST. ON DRUG ABUSE, META-ANALYSIS OF
DRUG ABUSE PREVENTION PROGRAMS 69, 69 (William J. Bukoski ed., 1997).
81. But one study found that some workers preferred urinalysis testing to personality testing.
See Joseph G. Rosse et al., Personality and Drug Testing: An Exploration of the Perceived Fair-
ness of Alternatives to Urinalysis, 10 J. Bus. & PSYCHOL. 459 (1996).
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FIGURE 2: EXPANDED CAUSAL CHAIN
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problems
course, psychomotor testing will pick up impaired performance due to
factors other than drug use-alcohol consumption, age, lack of sleep,
depression, and so on. Some of these other factors are preventable.
Hence, a program of random psychomotor testing may well be an ef-
fective deterrent against drug use, but also against alcohol use, sleep
deprivation, and other factors that impair safety. At the same time,
not everyone who is using a psychoactive drug will show impaired per-
formance on such tests. The NRC notes that "many employees who
do work under the influence may be able to compensate for their im-
pairment, and there is a substantial amount of variation across individ-
uals as to how a specific drug at a given dose affects performance. '82
As discussed below, this illustrates the tension between the "crimi-
nal deviance" and "safety regulation" framings of the problem. It also
calls into question the relative importance of the stated motives for
use testing: deterring drug use and preventing accidents. A prefer-
ence for drug testing over psychomotor testing suggests that use test-
ing is really about drug control rather than safety. This is also shown
by the fact that drug testing is more common than alcohol testing,83
even though the link between alcohol and accidents is better estab-
82. UNDER THE INFLUENCE, supra note 15, at 145.
83. One article presented these statistics:
Clearly, drug testing is still more prevalent than alcohol testing. For example, 36.0
percent of worksites with more than 50 employees conduct alcohol testing for appli-
cants or current employees or both, while the corresponding prevalence for drug testing
is 53.7 percent.... By contrast, 20.2 percent of worksites test for drugs, but do not test
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lished.84 Granted, it may be easier to consume alcohol without intoxi-
cation than cannabis or other drugs. 85  And alcohol is far more
prevalent, meaning far more positive test results-though from a
safety perspective that is not much of an argument at all.
Use testing may also have some unintended consequences. Theo-
retically, it could encourage users to substitute less detectable intoxi-
cants. In 1995, 20% of worksites tested for illicit drugs but not for
alcohol.8 6 The most commonly tested substances are the NIDA-5:
marijuana, cocaine, PCP, opiates, and amphetamines. Thus, users
might shift from the NIDA-5 to other illicit drugs like MDMA (Ec-
stasy) and barbiturates, or from illicit drugs to alcohol. I am unaware
of studies examining such substitution effects, 87 but these effects have
been linked to other policies. There is some evidence that users sub-
stitute marijuana for hard drugs when marijuana is decriminalized,88
and that users substitute marijuana for alcohol when the legal drink-
ing age is raised 89 or beer prices increase.90 Because marijuana has
the longest window of detectability in urinalysis, one might see a shift
toward less readily detectable substances like MDMA, amphetamines,
and barbiturates.
A related concern is that use testing will drive users away from test-
ing organizations-workplaces, schools, sports teams, and the mili-
tary. This might make those particular organizations safer, but it
displaces the harm to other settings where use might even escalate.
Professor Robert Taylor offers a formal model of this mechanism, ar-
for alcohol.... [T]he prevalence of drug testing for applicants is more than twice that
of alcohol testing (45.9 percent, versus 21.7 percent).
Hartwell et al., supra note 78, at 30 (citation omitted).
84. See WAYNE HALL & ROSALIE LICCARDO PACULA, CANNABIS USE AND DEPENDENCE:
PUBLIC HEATH AND PUBLIC POLICY 39-45 (2003).
85. On the other hand, some illicit drugs (for example, cocaine and amphetamines) in modest
doses improve psychomotor functioning, as American and other militaries have long known.
86. Hartwell et al., supra note 78, exhibit 1 at 29.
87. One study presents evidence consistent with a shift from marijuana and cocaine use to
increased alcohol use among tested athletes relative to nontested athletes, although the authors
did not draw such a conclusion, and the design precludes causal inference. See Robert H.
Coombs & Frank J. Ryan, Drug Testing Effectiveness in Identifying and Preventing Drug Use, 16
AM. J. DRUG & ALCOHOL ABUSE 173 (1990).
88. See Karyn E. Model, The Effect of Marijuana Decriminalization on Hospital Emergency
Room Drug Episodes: 1975-1978, 88 J. AM. STAT. ASs'N 737 (1993).
89. See John DiNardo & Thomas Lemieux, Alcohol, Marijuana, and American Youth: The
Unintended Consequences of Government Regulation (Nat'l Bureau of Econ. Research, Working
Paper No. 4212, 1992).
90. Frank J. Chaloupka & Adit Laixuthai, Do Youths Substitute Alcohol and Marijuana?
Some Econometric Evidence, 23 E. ECON. J. 253, 273 (1997) ("[T]he results presented here imply
that the combination of higher full prices for alcoholic beverages and a lower full price for mari-
juana will reduce the probability of youth motor vehicle accidents, both fatal and non-fatal.").
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guing that random testing of student athletes will have offsetting
effects:
1. Use will decrease among those inframarginal athletes who con-
tinue to participate.
2. Use will likely increase among those marginal athletes who
cease to participate.
The net effect on overall student drug use is ambiguous in sign-
overall student drug use may fall or rise after the imposition of test-
ing, and any reduction achieved will likely be smaller than expected.
... Holding overall use fixed, redistributing drug use from low-
level users to high-level users may be considered undesirable, espe-
cially if the negative health effects are very small for low-level use
but extremely large for high-level use.9'
A similar argument is suggested by "labeling theory" in criminol-
ogy.92 Labeling theory predicts that legal controls can actually en-
hance the likelihood of future offenses if the stigma associated with
criminal sanctioning alienates the individual from conventional soci-
ety. Alienation encourages contact with criminally involved referent
groups, and weakens the reputational costs that may restrain devi-
ance-thus creating a self-fulfilling prophecy.
Evidence supports this prediction, but the results are not conclusive.
Neither Mehay and Pacula nor Bachman found any evidence linking
past drug use to self-selection into the military. 93 On the other hand,
using the 1994 NHSDA survey, John Hoffmann and Cindy Larison of
the National Opinion Research Center found that those using mari-
juana or cocaine at least weekly were more likely to work for compa-
nies that had no testing program. 94 And the NHSDA 1994/1997
workplace analysis suggested that current users were more likely than
nonusers to say they would avoid working for an employer who con-
ducts pre-employment screening (22% versus 4%), random drug test-
ing (29% versus 6%), or "for cause" testing (24% versus 10%). 9 5
III. SAFETY TESTING
Part III of this Article presents a review of several studies of safety
testing. Safety testing is examined from its initial use in the 1970s to
91. Robert Taylor, Compensating Behavior and the Drug Testing of High School Athletes, 16
CAro J. 351, 353-62 (1997).
92. See generally JOHN BRAITHWAITE, CRIME, SHAME AND REINTEGRATION (1989).
93. See generally Bachman et al., supra note 48; Mehay & Pacula, supra note 50.
94. John Hoffmann & Cindy Larison, Drugs and the Workplace 9 (Nat'l Opinion Research
Ctr. at the Univ. of Chi., 1998), available at http://www.norc.org/new/drugwork.pdf.
95. NHSDA RESULTS, supra note 11, tbl.5.4.
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its current use in the so-called Rave era. The results of these studies
are surveyed, and the effects of safety testing on both prevalence re-
duction and harm reduction are analyzed.
A. Prevalence of Testing
1. The Seventies
Even in its heyday, safety testing of illicit drugs was extremely rare.
Between roughly 1972 and 1984, safety testing was conducted by inde-
pendent local laboratories run by universities, nonprofits, and health
centers.96 These laboratories tested anonymous samples dropped off
at street locations or submitted through the mail. The samples in-
cluded a wide variety of illicit substances, including cannabis products,
amphetamines, barbiturates, opiates, and various psychedelic drugs.
Although these laboratories were scattered around the country, rela-
tively few communities had a local center, and the utilization of na-
tional services was sparse. For example, PharmChem's national
testing program-the largest such program in the 1970s-analyzed a
total of 10,778 samples alleged to be cocaine between 1973 and 1983. 97
In 1982, PharmChem's busiest year of cocaine testing, they received
1385 samples. 98 But there were at least 3 million U.S. cocaine users in
1973, and at least 12 million in 1983. 99 Under the most optimistic as-
sumption that each sample came from a different user, only 0.012% of
all users participated in their testing. Even if PharmChem accounted
for only 1% of the national market for street testing-almost certainly
far below their actual share-that would still imply that only 1% of all
users had samples tested that year.
2. The Rave Era
The picture is similar for the late 1990s and early 2000s. DanceSafe
is the major source of samples for the EcstasyData.org testing opera-
tion.100 EcstasyData.org tested only 1521 samples alleged to be
96. See John K. Brown & Marvin H. Malone, Some U.S. Street Drug Identification Programs,
NS13 J. AM. PHARMACEUTICAL Ass'N 670, 670-71 (1973); Edward R. Kealy & Randall Webber,
An Interpretation of Trends in Street Drug Analysis Programs: Whom Do They Serve?, 7 J.
PSYCHEDELIC DRUGS 281 (1975).
97. Charles L. Renfroe & T.A. Messinger, Street Drug Analysis: An Eleven Year Perspective
on Illicit Drug Alteration, 1 SEMINARS ADOLESCENT MED. 247 tbl,1 at 248 (1985).
98. Id.
99. SUSAN S. EVERINGHAM & C. PETER RYDELL, MODELING THE DEMAND FOR COCAINE
xi-xiii (1994).
100. DanceSafe: Local Chapters, http://www.dancesafe.org/localchapters.php (last visited
Feb. 5, 2007).
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MDMA between 1996 and 2006.101 To put this in perspective, in 2001
an estimated 3.2 million Americans used MDMA at least once 10 2-1.7
million of them for the first time. 0 3 In that year, DanceSafe tested
only 332 samples, which accounted for at most 0.01% of users, and
this time their operation nearly cornered the market.
At present, use testing is far more common than safety testing.
While safety testing may have an important impact on the lives of
those who submit samples, they account for only a negligible fraction
of users. Thus, any aggregate impact of safety testing must be due to
the diffusion of this information and its use by rave organizers and
harm reduction activists.
The low prevalence of safety testing is not difficult to explain. The
legal risk to participants is the most obvious factor, 0 4 but there are
others. Volunteering a useable sample means giving away a valuable
commodity. And the test results, once publicized, are a public good,
and hence subject to free riding by nonparticipants. Another consid-
eration is the high cost. Most of the 1970s testing programs appear to
101. EcstasyData.org: Ecstasy Lab Testing Simple Statistics, http://www.ecstasydata.org/data-
stats.php?row=summary&col=year&percent=0 (last visited Feb. 5, 2007).
102. SAMHSA, U.S. Dep't of Health & Human Servs.. Illicit Drug Use Table H.1, http://
www.oas.samhsa.gov/NHSDA/2klNHSDA/vol2/appendixh-l.htm (last visited Feb. 5, 2007).
103. SAMHSA, U.S. Dep't of Health & Human Servs., Incidence Table 4.8A, http://www.
oas.samhsa.gov/NSDUH/2k4nsduh/2k4tabs/Sect4peTabslto5O.htm#tab4.8a (last visited Feb. 5,
2007).
104. 1 have found surprisingly little discussion of the legal status of anonymous testing. By
definition, the samples are illegal, and I presume that only those laboratories with a specific
DEA license to handle illicit drugs may do so without legal risk. A website discussion of Ecstasy
test kits offered the following frequently asked question and response:
There is some question as to the legal status of testing kits in the U.S. Many states
include wording in their paraphernalia laws which include[s] anything which "identify,
analyze, or test" scheduled substances. This wording is not included in the federal par-
aphernalia laws. Arguably, the ecstasy testing kits do not fit within this category as
they only verifiably test for the absence of MDMA or other controlled substances. (i.e.
if a sample does not turn a color, we can be reasonably sure that there is no MDMA
present, however if the sample turns black it could mean that [MDMA] is present or it
could indicate the presence of another completely unrelated substance).
These kits have been widely available for over a year and we have heard of no legal
problems either with their sale or possession. We know this isn't a very satisfactory
answer, but the U.S. legal system is often confusing on points like this. As a general
rule, if people aren't being prosecuted for it, it's unlikely that you will be.
Because it's not federally illegal, importation should not cause any legal problems,
but many people choose to avoid having to deal with customs by order [sic] from a
vendor on their own continent. We do not currently have any information about the
legality of testing kits in countries other than the United States.
Erowid MDMA Vault: Ecstasy Testing Kit FAQ, http://www.erowid.org/chemicals/mdma/
mdma-faq-testing-kits.shtml (last visited Feb. 5, 2007).
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have collapsed due to loss of funding rather than legal intervention,
and few users can or will pay the high cost of screening. 10 5
B. Testing Results
1. The Seventies
Table 1 shows variations in the purity of amphetamine and cocaine
samples at several testing centers from 1973 to 1983. The results cover
different time spans and geographic locations, so the lack of conver-
gence is not meant to indicate the reliability of the estimates. But the
data suggest that street drug buyers were extremely vulnerable to
fraudulent sales. For three of five laboratories, a majority of samples
alleged to be amphetamines contained adulterants; at two sites, 50%
to 67% of the tested samples contained only substances other than
amphetamines. For cocaine, the quality was more predictable, but in
the three laboratories for which data are available, at least 33% of the
tested cocaine samples were adulterated, and about 20% contained no
cocaine at all.
TABLE 1: PERCENT OF AMPHETAMINE AND COCAINE SAMPLES
THAT WERE ADULTERATED, VARIOUS LABORATORIES,
1971-1983.106
Amphetamine Cocaine
Same as Alleged + Adulterants Same as Alleged + Adulterants
PROGRAM # alleged adulterants only # alleged adulterants only
Analysis Anonymous
(PharmChem), 2018 12% 21% 67%
1973-1983
LA County Street
Drug Identification 473 27% 23% 50% 614 58% 23% 19%
Program, 1971-1980
Univ. of the Pacific, 68 54% 18% 28% 27 67% 19% 15%
early 1970s
LAG-USC Med. 123 18% 45% 37% 100 57% 23% 20%
Ctr., early 1970s
Metro Drug Aware- 46 72% 4% 24%
ness, early 1970s
105. The EcstasyData.org website currently addresses the excessive costs:
Ecstasy Testing Project Currently Out Of Funds (Aug 1, 2005). The Ecstasy Testing
Program has run out of funds. Testing costs $1,700 per month in laboratory fees for 15
pills / month with a $30 co-pay. If you would like to pay for the entire lab cost for the
pill ($115 USD), you can have your pill tested.
EcstasyData.org: Ecstasy Lab Testing & Analysis Results, http://www.ecstasydata.org/ (last vis-
ited Feb. 5, 2007).
106. J.K. Brown & M.H. Malone, Status of Drug Quality in the Street-Drug Market-An
Update, 9 CLINICAL TOXICOLOGY 145 tbls.5-6 at 154-55 (1976); Renfroe & Messinger, supra
note 97, tbl.3 at 251; Edward C. Klatt et al., Misrepresentation of Stimulant Street Drugs: A
Decade of Experience in an Analysis Program, 24 CLINICAL ToxICOLOGY 441 (1986).
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Table 2 shows data from the national testing program of
PharmChem's Analysis Anonymous for 1973 to 1983. The likelihood
of adulteration varied considerably across years. This reflects small
sample sizes; it may also be influenced by variations in the geographic
origin of the samples. But the data suggest that cocaine and MDMA
were less likely than amphetamines and methamphetamine to be
adulterated with other drugs. But unadulterated samples never ex-
ceeded 80% (60% across the full period), and in only one year could
users have had a better than 50% chance of buying cocaine without
sugar added.
TABLE 2: PERCENT OF UNADULTERATED SAMPLES IN ANALYSIS
ANONYMOUS TESTS, 1973-1983107
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
Averages
Amphet- Metham-
amine phetamine
11% 38%
2. The Rave Era
Figure 3 plots trends in MDMP
and other organizations and tested
riod-1999 to 2005-sample sizes
Cocaine
Cocaine (no sugar)
60% 29%
MDMA
55%
\ samples collected by DanceSafe
by EcstasyData.org. Over this pe-
ranged from 69 to 333. A fairly
constant 40% to 50% of the samples contained no MDMA; they in-
stead contained some other stimulant (30%), some near-analogue of
MDMA (15%), or a dissociative drug (12%). The rate of pure
MDMA dropped from around 50% in 1999-2001 to a low near 10%
in 2004, as an increasing number of samples contained MDMA mixed
with adulterants. In 2005, samples were equally likely to contain pure
MDMA, adulterated MDMA, or no MDMA.
107. Charles L. Renfroe, MDMA on the Street: Analysis Anonymous®, 18 J. PSYCHOACIVE
DRUGS 363 fig.2 at 365 (1986).
48% 40% 70% - -
25% 33% 63% 25% -
6% 36% 63% 5% 0%
8% 51% 56% 12% 100%
9% 38% 55% 28% 20%
6% 32% 56% 25% 17%
7% 30% 48% 25% 58%
1% 12% 47% 30% 25%
5% 25% 53% 36% 78%
18% 22% 54% 38% 93%
6% 37% 77% 61% 57%
0% 78% 80% - 100%
0% 63% 59% - 52%
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FIGURE 3: ECTASYDATA.ORG LAB RESULTS 1999-2005108
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Dr. Matthew Baggott and his colleagues published a more system-
atic analysis of 107 Ecstasy street samples in the Journal of the Ameri-
can Medical Association in 2000.109 They found that 29% "contained
identifiable drugs but no MDMA or analogue."110 Twenty-three pills
contained the antitussive dextromethorphan, which can be dangerous
in high doses or in combination with MDMA.'tl Other pills contained
caffeine, ephedrine, pseudoephedrine, and salicylates; nine contained
no drugs at all. 112
There are two reasons to expect any given test result to be far more
accurate for safety testing than for use testing. First, with safety test-
ing, samples come from intended users who label what the sample is
alleged to be (MDMA, etc.). Thus, there is no risk of falsely identify-
108. Figure 3 is the plot of EcstasyData lab results for 1999-2005. EcstasyData.org: Ecstasy
Lab Testing Sample Statistics-Ecstasy Pill Reports, http://www.ecstasydata.org/datastats.php?
row=summary&percent=l (last visited Feb. 5, 2007).
109. Matthew Baggott et al., Research Letter to the Editor, Chemical Analysis of Ecstasy
Pills, 284 J. AM. MED. ASS'N 2190 (2000).
110. Id.
111. Id.
112. Id. A recent literature review paints a different picture; it argues that "non-MDMA
tablets are now very infrequent, with purity levels between 90% and 100%" and that "[tihe
[E]cstasy purity problem was predominantly a phenomenon of the mid to late 1990s, when many
tablets contained substances other than MDMA." A.C. Parrott, Is Ecstasy MDMA? A Review
of the Proportion of Ecstasy Tablets Containing MDMA, Their Dosage Levels, and the Changing
Perceptions of Purity, 173 PSYCHOPHARMACOLOGY 234, 234 (2004). But most of Professor Par-
rott's data come from European and Australian sources, where the higher purity rates may be
attributable to less vigorous law enforcement. Id. at 235-36.
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ing a person as a user, and the tester knows what to look for. Second,
use testing is necessarily distorted by the fact that the samples come
from the body, and are therefore vulnerable to contaminants, water
loading, and other factors.
At an aggregate level, test results would seem to be less accurate for
safety testing than for use testing, at least for random use testing. Be-
cause safety testing is voluntary, there is no coercion or threat to civil
liberty, but the samples are also unlikely to be statistically representa-
tive. The direction of any selection bias is hard to identify. Safety
testing volunteers may be more cautious, wealthier, or better edu-
cated, and their samples may disproportionately represent the results
of suspicious transactions and dealers. Still, tests of drugs seized by
law enforcement agents often show high levels of impurity, despite a
very different set of sampling biases.'t 3
The remarkably low and variable purity rates in the safety testing
data have implications for the interpretation of use testing data, as
well as other sources of drug indicator data. Typically, use testing
targets a specific set of illicit drugs and does not attempt to detect or
identify adulterants. Because the samples are not volunteered as
drugs or labeled with street names, use testing samples may test nega-
tive even when the source was using street drugs. As noted above,
such false negatives will occur due to the presence of nontested street
drugs, or because the critical sampling periods of the target drugs have
passed.' 14 But the safety testing data suggest that false negatives will
also occur because tested individuals who were trying to use a NIDA-
5 drug unwittingly used something else. On the other hand, the Drug
Abuse Warning Network (DAWN) annual series,1 15 which records
emergency room "drug mentions," may overstate the link between the
mentioned drugs and acute health crises, because someone who men-
tions a drug may have actually consumed something entirely different.
C. Effects on Drug Use
To date, I have not been able to locate any empirical study of the
effects of safety testing on levels of drug use. This is hardly surprising;
safety testing has always been rare and research on safety testing is
113. Seized samples of heroin and cocaine base in the DEA's System to Retrieve Information
from Drug Evidence (STRIDE) database are typically at or below 50% purity. Joel L.
Horowitz, Should the DEA's STRIDE Data Be Used for Economic Analyses of Markets for
Illegal Drugs?, 96 J. AM. STAT. Ass'N 1254, 1257 (2001).
114. See supra notes 42-44 and accompanying text.
115. See Jonathan P. Caulkins et al., Describing DAWN's Dominion, 22 CoNTEMP. DRUG
PROas. 547 (1995).
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even rarer." 6 Moreover, safety testing is not intended to influence
the prevalence of drug use per se; it is intended to prevent harmful
consequences and make users more cautious about their behavior.
Still, there are good reasons to consider the question. From a hawk-
ish perspective, one may reasonably ask whether safety testing en-
courages drug use, either wittingly or unwittingly. Put another way,
does safety testing send the wrong message? I have analyzed this
question elsewhere and suggested two plausible answers. 117
One is a rhetorical mechanism; a harm reduction intervention may
encourage use by implying that drug use is acceptable or even desira-
ble. What messages does safety testing send? DanceSafe's statement
of purpose describes its goal as harm reduction-protecting the health
and safety of "non-addicted, recreational drug users":
DanceSafe is a nonprofit, harm reduction organization promoting
health and safety within the rave and nightclub community....
Our volunteers staff harm reduction booths at raves, nightclubs
and other dance events where they provide information on drugs,
safer sex, and other health and safety issues concerning the elec-
tronic dance community (like driving home safely and protecting
one's hearing).
We also provide adulterant screening or pill testing services for
[E]cstasy users. Pill testing is an important harm reduction service
that saves lives and reduces medical emergencies by helping
[E]cstasy users avoid fake and adulterated tablets that often contain
substances far more dangerous than real [E]cstasy.
Our information and services are directed primarily towards non-
addicted, recreational drug users. Non-addicted drug users are an
under-served population within the harm reduction movement, de-
spite the fact that they comprise the vast majority of drug users in
our society. While many organizations exist that provide services to
drug-dependent individuals, few groups address the needs of the
majority of non-addicted, recreational users. We hope to fill this
gap. When needed, we will always refer people to appropriate
treatment programs. 118
They also provide a disclaimer:
Disclaimer: This website provides health and safety information
only. We neither condemn nor condone the use of any drug.
116. I would like to note that the entire published literature regarding this topic fits on my
desk.
117. See generally MACCOUN & REUTER, DRUG WAR HERESIES, supra note 6; Robert J. Mac-
Coun, Anticipating Unintended Consequences of Vaccine-Like immunotherapies and Depot
Medications for Addictive Drug Use, in NEW TREATMENTS FOR ADDICTION: BEHAVIORAL, ETH-
ICAL, LEGAL, AND SOCIAL QUESTIONS 241 (Henrick J. Harwood & Tracy G. Myers eds., 2004);
MacCoun, Psychology of Harm Reduction, supra note 6.
118. About DanceSafe, http://dancesafe.org/documents/about/index.php (last visited Feb. 5,
2007).
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Rather, we recognize that recreational drug use is a permanent part
of our society, and that there will always be people who use drugs,
despite prohibition. The drug information we provide, therefore, is
meant to assist users in making informed decisions about their use.
We do not make the claim, nor do we imply, that the use of any
drug can ever be completely safe. All drug use contains inherent
risks. We assume no responsibility for how the information on this
site is used. 119
But it is possible that consumers infer tacit messages from
DanceSafe and related organizations. Psycholinguistic theory and re-
search suggest that people readily draw additional inferences that are
implied by an actor's conduct, regardless of whether those inferences
were endorsed, or even intended, by the actor. 120 The very way that
test results are framed implies that safety testing treats drug use in a
less stigmatizing way than use testing does. In safety testing, a posi-
tive test is pure, and a negative test denotes failure and contamination.
In use testing, it is the positive test that connotes failure; the user is
the contaminant.
Second, safety testing may encourage use by changing perceptions
of risk. At the margin, a harm reduction mechanism might change a
person's assessment of the expected value of taking drugs. If an inter-
vention reduces harm, then at the margin it should increase the attrac-
tiveness of the activity for most people. In my earlier treatment of
this topic, I reviewed evidence of this mechanism, much of it appear-
ing under the labels "compensatory behavior," "offsetting behavior,"
or "risk homeostasis.' 12t For example, there is strong evidence that
people drive faster when they have seat belts and airbags, both in
econometric analyses and in controlled experiments on driving test
tracks. 12 2 People smoke more when they have filters and low-tar ciga-
rettes.' 23 There is also some evidence that improved HIV treatments
are associated with increases in risky sexual behavior.124
119. DanceSafe: Parents, http://www.dancesafe.org/parents/ (last visited Feb. 5. 2007).
120. See generally Richard J. Harris & Gregory E. Monaco, Psychology of Pragmatic Implica-
tion: Information Processing Between the Lines, 107 J. EXPERIMENTAL PSYCHOL. 1 (1978); Rob-
ert S. Wyer, Jr. & Deborah H. Gruenfeld, Information Processing in Social Contexts:
Implications for Social Memory and Judgment, in 27 ADVANCES IN EXPERIMENITAL SOCIAL PSY-
CHOLOGY 49 (Mark P. Zanna ed., 1995).
121. MacCoun, Psychology of Harm Reduction, supra note 6, at 1203.
122. Robert S. Chirinko & Edward P. Harper, Jr., Buckle up or Slow down? New Estimates of
Offsetting Behavior and Their Implications for Automobile Safety Regulation, 12 J. POL'Y ANAL-
YSIS & MGMT. 270 (1993).
123. INST. OF MED., CLEARING THE SMOKE: ASSESSING THE SCIENCE BASE FOR TOBACCO
HARM REDUCTION 51 (Kathleen Stratton et al. eds., 2001).
124. Mitchell H. Katz et al., Impact of Highly Active Antiretroviral Treatment on HIV Ser-
oincidence Among Men Who Have Sex with Men: San Francisco, 92 AM. J. PUB. HEALTH 388
(2002); David E. Ostrow et al., Attitudes Towards Highly Active Antiretroviral Therapy Are Asso-
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How might safety testing have such effects? Conceivably, users
who were worried about drug quality in the illicit market may become
less worried if they learn through safety testing that drugs are gener-
ally pure in the local market. For better or worse, the purity rates
presented above suggest little cause for this concern. A somewhat dif-
ferent concern is that the very presence of a safety testing organiza-
tion, like DanceSafe, might make people feel more comfortable about
using MDMA. One survey has examined this possibility.125 At Mc-
Daniel College in Maryland, 719 students were asked whether they
had ever used Ecstasy, and "whether the presence of [DanceSafe]
would affect their decision to try [Ecstasy] for the first time or use it
(again). ' 126 Among the 75% who had never used, 69% said they
would not use under any condition, while 19% said they might be
more likely to use under such conditions, and 12% said that if they did
decide to use they would not be influenced by the presence of
DanceSafe. 127 Students that had previously used Ecstasy were equally
divided between those who thought they might be influenced (51%)
and those who did not (49%).128
But there are also reasons to think that safety testing, with its dis-
couraging purity statistics, might scare off some drug users. Some
fraction of participants who submit samples that turn out "dirty" pre-
sumably quit using, scale back their use, or at least delay their use
while seeking better samples. And to the extent that other potential
users see these statistics, the deterrent effect might be much broader
than the limited participation rates indicate.
Do current and potential users consider health risks-and the risk
of being ripped off-when they consider drug use? The health risks of
illicit drugs have long been a major focus of prevention campaigns,
and various studies show that current users worry about these risks. 12 9
One such study reported that users and nonusers of MDMA fre-
quently relied on the Internet for information about MDMA (about
ciated with Sexual Risk Taking Among HIlV-Infected and Uninfected Homosexual Men, 16 AIDS
775 (2002).
125. See Lauren Dundes, DanceSafe and Ecstasy: Protection or Promotion?, 17 J. HEAurH &
SOC. POL'Y 19 (2003).
126. Id. at 23.
127. Id. tbl.3 at 26.
128. Id. These results should be interpreted cautiously. not only because of the limited sample
coverage, but also because people are not accurate judges of how they will behave in a hypothet-
ical situation. See generally Richard E. Nisbett & Timothy DeCamp Wilson, Telling More Than
We Can Know: Verbal Reports on Mental Processes, 84 PSYCHOL. REV. 231 (1977).
129. See, e.g., Robert G. Carlson et al., Perceived Adverse Consequences Associated with
MDMA/Ecstasy Use Among Young Polydrug Users in Ohio: Implications for Intervention, 15
INT'L J. DRUG POL'Y 265 (2004).
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50% of each group).1 30 Users were more likely to seek information
from nongovernment sites (25% of all users) than from government
sites (less than 10% of users), and the nongovernment sources were
perceived to be more accurate (58% very or mostly accurate) than the
government sources (36% very or mostly accurate).
This Article makes no claim that health fears matter more than le-
gal fears. It is surprisingly difficult to find surveys comparing the rela-
tive importance of fear of legal risk and fear of health risk. The
Monitoring the Future survey conflates the two dimensions by asking,
"How much do you think people risk harming themselves (physically
or in other ways), if they [try marijuana]." 13' In the vast literature on
drug prevention and on the application of attitudinal theories-rea-
soned action, planned behavior, and the health belief model-to drug
use, there is almost no research directly reporting perceived fear or
risk of arrest or other legal sanctions. 132 On the other hand, the
smaller "perceptual deterrence" literature assesses perceived legal
risk (mostly for marijuana), but does not examine health concerns. 133
A few studies do suggest that health concerns are at least as important
as legal risks. An Australian survey by Professors Don Weatherburn
and Craig Jones found that those not using cannabis were more likely
to cite "worried about your health" (41%) than "[c]annabis is illegal"
(29%), "[y]ou are afraid you will be caught by the police" (10%), or
"[y]ou have drug testing in your workplace" (13%) as a reason for not
using.' 34 And the aforementioned McDaniel College survey, which
suggested that people might be influenced by DanceSafe, found that
130. Russel S. Falck et al., Sources of Information About MDMA (3,4-methylenedi-
odymethamphetamine): Perceived Accuracy, Importance, and Implications for Prevention
Among Young Adult Users, 74 DRUG & ALCOHOL DEPENDENCE 45, 48 (2004).
131. Monitoring the Future Data Tables and Figures tbl.7, http://www.monitoringthefuture.
org/data/05data/prO5t7.pdf (last visited Feb. 5, 2007).
132. Two prominent examples use this approach. Jerald G. Bachman et al., Explaining Recent
Increases in Students' Marijuana Use: Impacts of Perceived Risks and Disapproval, 1976 Through
1996, 88 AM. J. PUB. HEALTH 887 (1998); J. David Hawkins et al., Risk and Protective Factors for
Alcohol and Other Drug Problems in Adolescence and Early Adulthood: Implications for Sub-
stance Abuse Prevention, 112 PSYCHOL. BULL. 64 (1992).
133. See generally MacCoun, Drugs and the Law, supra note 45; Raymond Paternoster, The
Deterrent Effect of the Perceived Certainty and Severity of Punishment: A Review of the Evidence
and Issues, 4 JusT. Q. 173 (1987).
134. Don Weatherburn & Craig Jones, Does Prohibition Deter Cannabis Use?, 58 BUREAU
CRIME STAT. & RES., Aug. 2001, at I tbl.2 at 5, available at http://www.cannabislegal.de/studien/
nsw/b58.htm. This survey was conducted in New South Wales, Australia, a state that retains
marijuana criminalization at a time when several other Australian states have decriminalized
possession. However, enforcement is still more lax in Australia than in the United States.
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both users and nonusers worried more
than about legal sanctions. 135
FIGURE 4: SURVEY OF COLLEGE
E = ECSTASY (MDMA); DS
80% .
about the purity of Ecstasy
STUDENTS BY DUNDES
= DANCESAFE
1 3 6
% who fear E in % who fear % who say fears % who fear % who support
its pure form additives to E of pure E and its criminal sanctions DS' E testing
additives affect from E use
their E use
D. Effects on Drug-Related Harm
Surprisingly, there is no direct evidence on the harm reduction ben-
efits of anonymous safety testing. It is reasonable to assume that
those who voluntarily submit samples care about the results, and that
the testing allows them to avoid ingesting dangerous or addictive adul-
terants. If so, we can say that the aggregate impact is small, but the
impact on individual participants is meaningful.
But a broader harm reduction benefit occurs through the testing
messages posted by safety testing organizations. These messages can
be quite specific. For example, DanceSafe and EcstasyData.org post
photographs of contaminated or adulterated "brands" of MDMA, to-
gether with the date and geographic region of the purchase. I have
already reviewed evidence that a sizeable fraction of MDMA users
135. See fig.4.
136. See Dundes, supra note 125, tbls.3-4 at 26-27. Both factors were significantly associated
with drug use, with eta2(1) = 4.11 (p < 0.05) and 5.95 (p < 0.02), respectively.
[Vol. 56:507
IN THE SHADOW OF CRIMINAL LAW
say they read such information on the web, that they view the infor-
mation as credible, and that their health and safety matter to them.137
So it is possible that for every anonymous sample provider who is
helped, there are many more potential users who are also helped. But
again, I am not aware of direct evidence of the harms averted by
safety testing.
As with use testing, there may be other, less direct consequences,
some of which may be undesirable. There may be a substitution from
one type of drug to another; for example, users may come to distrust
MDMA and seek out other substances. Some of those substances are
arguably more benign (e.g., psilocybin); others may be more un-
healthy (e.g., alcohol, methamphetamine).
In theory, widespread safety testing could improve the quality of
illicit drugs in the marketplace. This provides a stark illustration of
the tension between harm reduction and use reduction, because better
drug quality should increase demand. But it is difficult to make firm
predictions here. In an ordinary market, sellers should charge more
for higher quality goods, and buyers should be willing to pay more. In
the long run, sellers of low-quality goods can expect to lose customers
to sellers offering higher quality goods at the same price. But illicit
drugs are not an ordinary market. Professors Jonathan Caulkins and
Rema Padman found that prices rose with purity for white and brown
heroin and powder cocaine, but surprisingly, they were unable to de-
tect an effect of purity on the prices of crack, methamphetamine, or
black tar heroin. 138 To help explain this puzzle, Professors Peter Reu-
ter and Caulkins detail a number of distinctive features of illicit drug
markets, including the multistage distribution networks connecting
producers and consumers, uncertainty about quality, turnover of buy-
ers and sellers, and a limited ability to signal quality through consis-
tent branding.' 39 Many of these features produce the kind of
informational problems discussed in Professor George Akerlof's clas-
sic paper on "the market for lemons.' 140 A lemons market occurs
when there is an informational asymmetry such that sellers know
more than buyers about a good's quality. This asymmetry increases
the supply of low-quality goods, and can even collapse the market if
potential buyers refuse to make new purchases. One major difference
137. See supra notes 130-131 and accompanying text.
138. Jonathan P. Caulkins & Rema Padman, Quantity Discounts and Quality Premia for Illicit
Drugs, 88 J. AM. STAT. ASS'N 748, 752-53 & tbl.4 (1993).
139. P. Reuter & J.P. Caulkins, Illegal "Lemons": Price Dispersion in Cocaine and Heroin
Markets, 56 BULL. ON NARCOTICS 141 (2004).
140. George A. Akerlof, The Market for "Lemons": Quality Uncertainty and the Market
Mechanism, 84 Q.J. ECON. 488 (1970).
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from the classic lemons model is the higher likelihood of repeat buyer-
seller transactions in drug markets; the retail seller also has imperfect
knowledge of and control over quality.
From a use reduction standpoint, the highly variable quality of
drugs probably reduces the demand for illicit drugs. But from a harm
reduction standpoint, this feature of illicit markets is quite troubling.
First, it creates a high risk of overdose and illness, because adulterants
have a toxic effect and also because customers have difficulty cali-
brating their dosage. Second, it encourages disputes between sellers
and buyers, and given the illicit nature of their transactions, these dis-
putes cannot be taken to legal authorities and thus frequently result in
violence.14'
IV. CONCLUSION
In laboratories throughout the United States, technicians in white
lab coats are scanning samples with GC/MS equipment. Some of
these samples have not yet entered a human body; others come from a
body's hair, blood, or urine. The laboratory protocols are similar, but
they reflect very different ways of thinking about the control of drug-
related harms. Both are shaped-and in some ways distorted-by
criminal law and the way it frames the act of drug use as criminal
deviance.
Though it still receives heavy criticism, 142 use testing has a far less
malevolent public image than it did in 1972, when a piece in the New
England Journal of Medicine called it "Chemical McCarthyism." 143
Today, opinion surveys show that most citizens generally accept drug
testing, at least if it is done fairly, 144 and it continues to spread into
141. For a review of evidence, see Robert MacCoun, Beau Kilmer & Peter Reuter, Research
on Drugs-Crime Linkages: The Next Generation, in NAT'L INST. OF JUSTICE, U.S. DEP'T OF JUS-
TICE, TOWARD A DRUGS AND CRIME RESEARCH AGENDA FOR THE 21ST CENTURY: SPECIAL
REPORT 65 (2003). For a theoretical analysis, see Jonathan P. Caulkins et al., Can Supply Re-
strictions Lower Price? Violence, Drug Dealing and Positional Advantage, 5 CONTRIBUTIONS TO
ECON. ANALYSIS & POL'Y 1 (2006).
142. See, e.g., American Civil Liberties Union, Drug Policy: Drug Testing: Press Releases,
http://www.aclu.org/drugpolicy/testing/index.html (last visited Feb. 5, 2007); Drug Policy Alli-
ance: Drug Testing, http://www.drugpolicy.org/law/drugtesting/ (last visited Feb. 5, 2007); Na-
tional Organization for the Reform of Marijuana Laws (NORML), Drug Testing, http://www.
norml.org/index.cfm?Group-ID=3406 (last visited Feb. 5, 2007).
143. George D. Lundberg, Letter to the Editor, Urine Drug Screening: Chemical McCarthy-
ism, 287 NEW ENG. J. MED. 723 (1972).
144. See INFORMING AMERICA'S POLICY, supra note 13, at 198 ("For-cause testing is uncon-
troversial because it is generally perceived as fair and most likely helps to deter workers from
becoming intoxicated on the job."); Mary A. Konovsky & Russell Cropanzano, Perceived Fair-
ness of Employee Drug Testing as a Predictor of Employee Attitudes and Job Performance, 76 J.
APPLIED PSYCHOL. 698 (1991); Paul M. Mastrangelo & Paula M. Popovich, Employees' Attitudes
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more and more schools and workplaces. Use testing advocates try to
avoid the undesirable connotations of the criminal deviance framing.
In his 2004 State of the Union address, President George W. Bush
offered this justification: "Tonight I proposed an additional $23 mil-
lion for schools that want to use drug testing as a tool to save chil-
dren's lives. The aim here is not to punish children, but to send them
this message: We love you, and we don't want to lose you."'1 4 5 Simi-
larly, a website run by Robert DuPont's Institute for Behavioral
Health states that "[s]tudent drug testing programs are designed to
prevent drug use, not to punish use."' t46
Still, it seems clear that criminal law shapes the way use testing has
spread. Operating in the shadow of criminal law, use testing has been
able to overcome the resistance of those employees and students who
resent its intrusive surveillance. The criminal law framing creates a
rhetorical asymmetry favoring testing advocates. Those who oppose
testing can be covertly or even overtly portrayed as advocates for drug
use rather than advocates for civil liberties. And the criminal law
framing also makes any nonpenal consequences of a positive test look
more benevolent and less intrusive than they might otherwise seem.
The criminal deviance framing also distorts thinking about the effec-
tive management of risk. It focuses attention on use, but it distracts us
from more direct ways of identifying safety risks, like routine psycho-
motor testing and mental health screening. Finally, the fear of use
testing and its social and legal sanctions may drive users away from
schools, activities, and jobs that might otherwise benefit them. It may
deter some drug use, while displacing other drug use to different
settings.
Criminal law has an equally powerful effect on safety testing. In a
prohibition regime, there are few incentives for sellers to participate
in safety testing-indeed, there are incentives for adulterating drugs-
and significant legal risks for users who wish to test their street
purchases. Yet a remarkably high number of tested samples are full of
adulterants. In 2005, almost 20% of American high school students
Toward Drug Testing, Perceptions of Organizational Climate, and Withdrawal from the Employer,
15 J. Bus. & PSYCHOL. 3 (2000); Bernadette M. Raciot & Kevin J. Williams, Perceived Invasive-
ness and Fairness of Drug-Testing Procedures for Current Employees, 23 J. APPLIED SOC.
PSYCHOL. 1879 (1993); Rosse et al., supra note 81.
145. President George W. Bush, State of the Union Address (Jan. 20, 2004), available at http://
www.whitehouse.gov/news/releases/2004/01/20040120-7.html.
146. Prevention Not Punishment: Background, www.preventionnotpunishment.org (last vis-
ited Feb. 5, 2007).
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used an illicit drug other than marijuana; 147 12% of eighth graders and
27% of twelfth graders have done so in their lifetimes. 148 Those drugs
are already risky, and because those drugs are obtained in an illicit
market, their consumers face the additional risk of unknown adulter-
ants. Safety testing not only protects participants from those adulter-
ants, it also provides credible information about the risks of the
market in a way that may discourage more use than it encourages.
The expressive and crime-controlling functions of criminal law are
often in tension with other social goals, including distributive justice,
restorative justice, and risk regulation. The tension is often framed as
a contrast between an ex ante signal and an ex post situation, as in
Professor Meir Dan-Cohen's analysis of conduct versus decision
rules, 149 or Professor John Braithwaite's analysis of deterrence versus
reintegrative shaming. 50 But the contrast between use testing and
safety testing involves a tension between three ex ante goals: moral
expression, deterrence, and consumer safety. Criminal law tells po-
tential users ex ante that our society disapproves of drug use, and that
we will punish it when it occurs. But empirically, it is clear that the
fear of legal sanctions plays only a small role in citizens' decisions
about intoxicants. Many will use drugs despite the law and its
messages. We routinely provide consumer safety information for a
wide variety of risks-cold medicines, lawn mowers, breakfast cereals,
and alcoholic beverages. But because MDMA, cocaine, and heroin
are illegal, if we provide safety information, we make them less risky
but also risk making them more popular.
This tension isn't insurmountable; it is simply a challenge. As with
needle and syringe exchanges and free condoms in high schools, the
tension between use reduction and harm reduction is a matter of de-
gree. The tension can and should be assessed empirically, and it can
be managed skillfully. But it requires us to accept some ambivalence
and ambiguity.
147. Monitoring the Future Data Tables and Figures tbl.2, http://www.monitoringthefuture.
org/data/05data/prO5t2.pdf (last visited Feb. 5, 2007).
148. Monitoring the Future Data Tables and Figures tbl.1, http://www.monitoringthefuture.
org/data/05datalpr05tl.pdf (last visited Feb. 5, 2007).
149. Meir Dan-Cohen, Decision Rules and Conduct Rules: On Acoustic Separation in Crimi-
nal Law, 97 HARV. L. REv. 625 (1984).
150. BRAITHWAITE, supra note 92.
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